IRCT20210519051345N44招募中Unknown
Investigating in vivo bioequivalence of Famotidine 40 mg/5 ml suspension manufactured by Omid Behboud Co.compared to innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney), Age (18-59 years)
排除标准
- •Smoking, History of cardiovascular disease, liver and kidney disease, Pregnancy, Alcohol and drug addiction, History of drug allergy
研究者
相似试验
已完成
Unknown
Bioequivalence study of Famotidine 40 mg coated tablets of Medava Pharmaceutical Company with Famotidine 40 mg coated tablets of Telomed Pharmaceutical Company of EnglandIRCT20130313012810N18Modava Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Famotidine 40 mgIRCT20200623047902N14Sanamed pharma company24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tabletIRCT20200105046010N85Tabriz University of Medical Sciences24
已完成
不适用
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
尚未招募
不适用
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24